What were the adverse events with OraVerse?
A. In multi-center, controlled, randomized double-blinded clinical trials there were no serious adverse events and no discontinuation due to adverse events. The majority of adverse events were mild and resolved within 48 hours. The frequency of adverse events was similar among OraVerse and control groups. In addition OraVerse had no effect on pain, post-treatment analgesic use, vital signs or oral mucosa compared to control.
